Institute of Molecular Health Sciences, ETH, Zurich, Switzerland

Director, Institute for Cancer Dormancy and Tumor Microenvironment, Albert Einstein College of Medicine, New York, USA

Associate Director for Translational Research and Director of Genitourinary Oncology in HOT Division, University of Minnesota–Masonic Cancer Center, USA

Associate Professor, Medical Oncology, Leader, Precision Oncology Analytics, Director, Thoracic Oncology Biorepository, Co-director, Thoracic Oncology Precision Medicine Center of Excellence, Upper Aerodigestive Oncology Program, Co-leader, Molecular Tumor Board, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, USA

Professor, Department of Oncology, University of Torino, Candiolo, Italy

Assoc. Professor, Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, Massachusetts

Chief, Breast Medical Oncology
Associate Director of Precision Medicine, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine
Scientific Director, the Englander Institute of Precision Medicine
Co-Leader, Meyer Cancer Center Management Team

Professor, Head of the Division of Clinical Studies, The Institute for Cancer Research, (ICR) and Royal Marsden, London, UK

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Professor, Deputy Director Cancer Research UK Manchester Institute, Senior Group Leader Clinical & Experimental Pharmacology, The University of Manchester, UK

Director, Rare Circulating Cells lab, Gustav Roussy, Paris, France

Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria

Institute for Research on Cancer and Aging Nice, France

Director Translational Molecular Medicine, SJCI PHS, Santa Monica CA, USA

Director, Breast Medical Oncology Clinic & Program, Medical Oncology Department, Institut Bordet, Associate Professor, Université Libre de Bruxelles, Chair, Breast Cancer Group, EORTC, Belgium

Oncologist and researcher at Weill Cornell Medicine and New York-Presbyterian Hospital

Dean’s Professor of Biological Sciences and Professor of Medicine, Biomedical Engineering, Aerospace & Mechanical Engineering, and Urology, USC Michelson CSI-Cancer, Los Angeles, California, USA

Executive Director of the Blood Profiling Atlas in Cancer (BloodPAC) USA

Professor of Analytical Chemistry – Clinical Chemistry, Analysis of Circulating Tumor Cells lab, Dept of Chemistry, University of Athens, Greece

Mayo Clinic, Rochester, Minnesota, USA

Medical Oncology Dept. & Translational Medical Oncology Group, University Clinical Hospital & Health Research Institute (IDIS); CIBERONC, Santiago de Compostela University School of Medicine, Santiago de Compostela (Spain) 

Professor and Director, Medical Physics and Biophysics, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA

Instituto de Neurociencias (CSIC-UMH), Alicante, Spain

Professor of Oncology and Pathology, Director of Translational Genetics, Ludwig Center for Cancer Genetics and Therapeutics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA

Professor of Medical Oncology, at the Institute Curie and University Paris Descartes, Paris, France

MD, Griffith University, Griffith Institute for Drug Discovery (GRIDD) and Menzies Health Institute Queensland (MIHQ), Saliva and Liquid Biopsy Translational Laboratory, Queensland, Australia

Professor and Assoc. Director for Clinical Research, Center for Thoracic Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, USA

Director, Barts Cancer Institute - Α Cancer Research UK Centre of Excellence, London, United Kingdom

Professor, Experimental Surgical Oncology, Heinrich Heine University, Düsseldorf, Germany

 Head, Division of Stem Cells and Cancer at the German Cancer Research Center (DKFZ), Heidelberg, Germany